Check nearby libraries
Buy this book
The success of any drug discovery project relies upon the quality of the lead that initiates the lead optimization process. What defines a 'quality lead', where these 'quality leads' come from and how one discovers them has been the subject of intense debate within the pharmaceutical industry, relies upon defining those properties that historically have led to successful drug discovery. This volume addresses these questions and specifically discusses diabetes, obesity and tuberculosis. Presents the latest research in the field of drug discovery Publishes.
Check nearby libraries
Buy this book
Previews available in: English
Subjects
Medicine, Pharmacy, Pharmaceutical chemistryShowing 1 featured edition. View all 1 editions?
Edition | Availability |
---|---|
1
Progress in Medicinal Chemistry
2007, Elsevier
electronic resource
in English
0080471315 9780080471310
|
aaaa
Libraries near you:
WorldCat
|
Book Details
Edition Notes
Cover; Progress in Medicinal Chemistry 45; Copyright page; Preface; Contents; List of Contributors; Chapter 1. Hit and Lead Identification: Efficient Practices for Drug Discovery; Chapter 2. DPPIV Inhibition: Promising Therapy for the Treatment of Type 2 Diabetes; Chapter 3. Recent Progress Toward Nonpeptide Ligands for the Melanocortin-4 Receptor; Chapter 4. Tuberculosis Chemotherapy: Recent Developments and Future Perspectives; Subject Index; Author Index (Vols. 1- 45); Subject Index (Vols. 1- 45).
Description based on print version record.
Classifications
External Links
The Physical Object
ID Numbers
Community Reviews (0)
Feedback?History
- Created July 6, 2019
- 2 revisions
Wikipedia citation
×CloseCopy and paste this code into your Wikipedia page. Need help?
September 16, 2021 | Edited by ImportBot | import existing book |
July 6, 2019 | Created by MARC Bot | Imported from Internet Archive item record |